APO RESEARCH · REPORT
Bioresorbable Medical Material
The bioresorbable medical material in this report contains polylactic acid (PLA), polyglycolic acid (PGA), polysaccharides, polycaprolactone (PCL) and PLGA.
Product & engineering
Understand the product.
The bioresorbable medical material in this report contains polylactic acid (PLA), polyglycolic acid (PGA), polysaccharides, polycaprolactone (PCL) and PLGA.
Selected research
Market Structure
Global Bioresorbable Medical Material Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The bioresorbable medical material in this report contains polylactic acid (PLA), polyglycolic acid (PGA), polysaccharides, polycaprolactone (PCL) and PLGA.
Global Bioresorbable Medical Material key players include Evonik, Corbion, DSM, Mitsui Chemicals, PCAS, etc. Global top five manufacturers hold a share over 50%.
USA is the largest market, with a share over 40%, followed by Europe and China, both have a share over 35% percent. In terms of product, PLA is the largest segment, with a share over 20%. And in terms of application, the largest application is Orthopedics, followed by Drug Delivery.
Read the full market overview
This report provides an overview of the global Bioresorbable Medical Material market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Bioresorbable Medical Material and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Bioresorbable Medical Material sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Bioresorbable Medical Material market size, projected growth trends, production technologies, key applications, and end-use industries.
Bioresorbable Medical Material Segment by Company
Evonik
Corbion
DSM
Mitsui Chemicals
PCAS
Poly-Med
KLS Martin
Bioresorbable Medical Material Segment by Type
Polylactic Acid (PLA)
Polyglycolic Acid (PGA)
Polysaccharides
Polycaprolactone (PCL)
PLGA
Bioresorbable Medical Material Segment by Application
Drug Delivery
Orthopedics
Others
Bioresorbable Medical Material Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bioresorbable Medical Material market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Bioresorbable Medical Material and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bioresorbable Medical Material.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Bioresorbable Medical Material market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Bioresorbable Medical Material manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Bioresorbable Medical Material in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Bioresorbable Medical Material in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Polylactic Acid (PLA)
- Polyglycolic Acid (PGA)
- Polysaccharides
- Polycaprolactone (PCL)
- PLGA
Applications
- Drug Delivery
- Orthopedics
- Others
Companies covered
- Evonik
- Corbion
- DSM
- Mitsui Chemicals
- PCAS
- Poly-Med
- KLS Martin
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Bioresorbable Medical Material Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Bioresorbable Medical Material Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Bioresorbable Medical Material Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Bioresorbable Medical Material Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Bioresorbable Medical Material Market Dynamics
- 2.1 Bioresorbable Medical Material Industry Trends
- 2.2 Bioresorbable Medical Material Industry Drivers
- 2.3 Bioresorbable Medical Material Industry Opportunities and Challenges
- 2.4 Bioresorbable Medical Material Industry Restraints
3 Bioresorbable Medical Material Market by Manufacturers
- 3.1 Global Bioresorbable Medical Material Revenue by Manufacturers (2021-2026)
- 3.2 Global Bioresorbable Medical Material Sales by Manufacturers (2021-2026)
- 3.3 Global Bioresorbable Medical Material Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Bioresorbable Medical Material Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Bioresorbable Medical Material Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Bioresorbable Medical Material Manufacturers, Product Type & Application
- 3.7 Global Bioresorbable Medical Material Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Bioresorbable Medical Material Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Bioresorbable Medical Material Players Market Share by Revenue in 2025
- 3.8.3 2025 Bioresorbable Medical Material Tier 1, Tier 2, and Tier 3
4 Bioresorbable Medical Material Market by Type
- 4.1 Bioresorbable Medical Material Type Introduction
- 4.1.1 Polylactic Acid (PLA)
- 4.1.2 Polyglycolic Acid (PGA)
- 4.1.3 Polysaccharides
- 4.1.4 Polycaprolactone (PCL)
- 4.1.5 PLGA
- 4.2 Global Bioresorbable Medical Material Sales by Type
- 4.2.1 Global Bioresorbable Medical Material Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Bioresorbable Medical Material Sales by Type (2021-2032)
- 4.2.3 Global Bioresorbable Medical Material Sales Market Share by Type (2021-2032)
- 4.3 Global Bioresorbable Medical Material Revenue by Type
- 4.3.1 Global Bioresorbable Medical Material Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Bioresorbable Medical Material Revenue by Type (2021-2032)
- 4.3.3 Global Bioresorbable Medical Material Revenue Market Share by Type (2021-2032)
5 Bioresorbable Medical Material Market by Application
- 5.1 Bioresorbable Medical Material Application Introduction
- 5.1.1 Drug Delivery
- 5.1.2 Orthopedics
- 5.1.3 Others
- 5.2 Global Bioresorbable Medical Material Sales by Application
- 5.2.1 Global Bioresorbable Medical Material Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Bioresorbable Medical Material Sales by Application (2021-2032)
- 5.2.3 Global Bioresorbable Medical Material Sales Market Share by Application (2021-2032)
- 5.3 Global Bioresorbable Medical Material Revenue by Application
- 5.3.1 Global Bioresorbable Medical Material Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Bioresorbable Medical Material Revenue by Application (2021-2032)
- 5.3.3 Global Bioresorbable Medical Material Revenue Market Share by Application (2021-2032)
6 Global Bioresorbable Medical Material Sales by Region
- 6.1 Global Bioresorbable Medical Material Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Bioresorbable Medical Material Sales by Region (2021-2032)
- 6.2.1 Global Bioresorbable Medical Material Sales by Region (2021-2026)
- 6.2.2 Global Bioresorbable Medical Material Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Bioresorbable Medical Material Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Bioresorbable Medical Material Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Bioresorbable Medical Material Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Bioresorbable Medical Material Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Bioresorbable Medical Material Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Bioresorbable Medical Material Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Bioresorbable Medical Material Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Bioresorbable Medical Material Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Bioresorbable Medical Material Revenue by Region
- 7.1 Global Bioresorbable Medical Material Revenue by Region
- 7.1.1 Global Bioresorbable Medical Material Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Bioresorbable Medical Material Revenue by Region (2021-2026)
- 7.1.3 Global Bioresorbable Medical Material Revenue by Region (2027-2032)
- 7.1.4 Global Bioresorbable Medical Material Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Bioresorbable Medical Material Revenue (2021-2032)
- 7.2.2 North America Bioresorbable Medical Material Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Bioresorbable Medical Material Revenue (2021-2032)
- 7.3.2 Europe Bioresorbable Medical Material Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Bioresorbable Medical Material Revenue (2021-2032)
- 7.4.2 Asia-Pacific Bioresorbable Medical Material Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Bioresorbable Medical Material Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Bioresorbable Medical Material Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Evonik
- 8.1.1 Evonik Company Information
- 8.1.2 Evonik Business Overview
- 8.1.3 Evonik Bioresorbable Medical Material Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Evonik Bioresorbable Medical Material Product Portfolio
- 8.1.5 Evonik Recent Developments
- 8.2 Corbion
- 8.2.1 Corbion Company Information
- 8.2.2 Corbion Business Overview
- 8.2.3 Corbion Bioresorbable Medical Material Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Corbion Bioresorbable Medical Material Product Portfolio
- 8.2.5 Corbion Recent Developments
- 8.3 DSM
- 8.3.1 DSM Company Information
- 8.3.2 DSM Business Overview
- 8.3.3 DSM Bioresorbable Medical Material Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 DSM Bioresorbable Medical Material Product Portfolio
- 8.3.5 DSM Recent Developments
- 8.4 Mitsui Chemicals
- 8.4.1 Mitsui Chemicals Company Information
- 8.4.2 Mitsui Chemicals Business Overview
- 8.4.3 Mitsui Chemicals Bioresorbable Medical Material Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Mitsui Chemicals Bioresorbable Medical Material Product Portfolio
- 8.4.5 Mitsui Chemicals Recent Developments
- 8.5 PCAS
- 8.5.1 PCAS Company Information
- 8.5.2 PCAS Business Overview
- 8.5.3 PCAS Bioresorbable Medical Material Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 PCAS Bioresorbable Medical Material Product Portfolio
- 8.5.5 PCAS Recent Developments
- 8.6 Poly-Med
- 8.6.1 Poly-Med Company Information
- 8.6.2 Poly-Med Business Overview
- 8.6.3 Poly-Med Bioresorbable Medical Material Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Poly-Med Bioresorbable Medical Material Product Portfolio
- 8.6.5 Poly-Med Recent Developments
- 8.7 KLS Martin
- 8.7.1 KLS Martin Company Information
- 8.7.2 KLS Martin Business Overview
- 8.7.3 KLS Martin Bioresorbable Medical Material Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 KLS Martin Bioresorbable Medical Material Product Portfolio
- 8.7.5 KLS Martin Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Bioresorbable Medical Material Value Chain Analysis
- 9.1.1 Bioresorbable Medical Material Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Bioresorbable Medical Material Production Mode & Process
- 9.2 Bioresorbable Medical Material Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Bioresorbable Medical Material Distributors
- 9.2.3 Bioresorbable Medical Material Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst